AstraZeneca PLC is 39.2x more valuable than Alkermes plc. by market capitalization ($286.27 B vs $7.31 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ALKS | AZN |
|---|---|---|
| Market cap | $7.31 B | $286.27 B |
| US-listed rank | #1122 | #45 |
| Revenue (latest FY) | $1.48B | - |
| Net income (latest FY) | $241.70M | - |
| Net margin | 16.4% | - |
| P/E (trailing FY) | 30.2 | - |
| SEC filings | 1,884 | 1,004 |
AstraZeneca PLC is 39.2x more valuable than Alkermes plc. by market capitalization ($286.27 B vs $7.31 B).
Full pages: Alkermes plc. and AstraZeneca PLC, or browse the full rankings.